| yu, yang |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
EMBER-4, NCT05514054: A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer |
|
|
| Recruiting | 3 | 6000 | Europe, Canada, Japan, US, RoW | Imlunestrant, LY3484356, Tamoxifen, Anastrozole, Letrozole, Exemestane | Eli Lilly and Company | Breast Neoplasms | 10/27 | 03/32 | | |
NCT06227117: Neoadjuvant Study of DV in Combination Toripalimab or Sequence Chemotherapy in HR-negative, HER2 Low-expressing Breast Cancer |
|
|
| Recruiting | 2 | 120 | RoW | Disitamab Vedotin Injection （18 weeks）, DV,RC48-ADC, Toripalimab （18weeks）, JS001, Carboplatin, Disitamab Vedotin Injection （12 weeks）, Sequential Epirubicin, Epirubicin, Sequential CTX, CTX, cyclophosphamide, Toripalimab （12weeks） | RemeGen Co., Ltd. | Breast Cancer | 12/25 | 12/26 | | |
| Recruiting | 2 | 30 | RoW | Neoadjuvant Chemotherapy in Combination with Toripalimab, HR+ HER2 breast cancer | First Affiliated Hospital of Zhejiang University | HR+/HER2- Breast Cancer | 06/26 | 06/29 | | |
| Recruiting | 2 | 35 | RoW | Neoadjuvant chemotherapy combined with Toripalimab | First Affiliated Hospital of Zhejiang University | TNBC, Triple Negative Breast Cancer | 10/26 | 10/29 | | |
TOUCH, NCT04425070: A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma |
|
|
| Active, not recruiting | 1/2 | 56 | RoW | ICE [ifosfamide+carboplatin+etoposide], GEMOX [gemcitabine+oxaliplatin], Tislelizumab | Antengene Corporation | Peripheral T-cell Lymphoma, NK/T-cell Lymphoma | 12/24 | 12/24 | | |
|
|
|
| Recruiting | 1/2 | 500 | Europe, Canada, Japan, US, RoW | Oral repotrectinib (TPX-0005), repotrectinib | Turning Point Therapeutics, Inc., Zai Lab (Shanghai) Co., Ltd. | Locally Advanced Solid Tumors, Metastatic Solid Tumors | 02/28 | 02/28 | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MATCH, NCT05354362: A Study of ATG-010 in Combination With ATG-008 in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma |
|
|
| Terminated | 1 | 7 | RoW | ATG-010 and ATG-008 | Antengene Corporation | Relapsed/Refractory Diffuse Large B-cell Lymphoma | 02/23 | 02/23 | | |
NCT05606224: The Effects and Mechanisms of Mindfulness Intervention for Emotional Distress |
|
|
| Recruiting | N/A | 200 | RoW | internet-based mindfulness intervention for emotional distress | Peking University, Nanjing Brian Hospital, Capital Medical University, Beijing Tiantan Hospital, Foshan Mental Health Center | Emotional Disorder | 08/23 | 08/23 | | |
PLEDGE, NCT05120180: Effect of ALND With Vein Branches Reservation on Postoperative Upper Limb Edema and Dysfunction in Breast Cancer |
|
|
| Active, not recruiting | N/A | 258 | RoW | axillary lymph node dissection with vein branches reservation, axillary lymph node dissection without vein branches reservation | Xiangyun Zong | Breast Cancer Lymphedema | 04/24 | 04/29 | | |
NCT06127875: Effects of Trying to Conceive Using an Home- or Hospital-based Ovulation Monitoring on Stress |
|
|
| Recruiting | N/A | 260 | RoW | | The First Hospital of Jilin University | Fertility Issues, Stress, Psychological | 11/24 | 11/24 | | |
| Recruiting | N/A | 1500 | RoW | | The First Hospital of Jilin University | Sperm, Fertility | 11/24 | 11/24 | | |
PLEDGE-R, NCT05246592: Effect of the Axillary Lymphatic /Vein Reflux Ratio on Postoperative Upper Limb Edema and Dysfunction in Breast Cancer |
|
|
| Active, not recruiting | N/A | 258 | RoW | Branches Sparing, None Branches Sparing | Xiangyun Zong | Breast Cancer Lymphedema | 04/24 | 04/29 | | |
CAPPELLA, NCT05512286: Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap Reconstruction |
|
|
| Recruiting | N/A | 80 | RoW | Preoperative radiotherapy, Postmastectomy radiotherapy | Fudan University, Huashan Hospital, Hunan Cancer Hospital, Cancer Hospital of Guangxi Medical University, Yunnan Cancer Hospital, Zhejiang Cancer Hospital, Henan Cancer Hospital | Breast Cancer | 07/26 | 10/27 | | |
